These data suggest that rAAV-SPA-TK injection induces high expression of HIF-1α by killing AT II cells, which possibly involves MSC differentiation in the AT II cell niche in COPD. The gene discussed is HIF1A; the disease is chronic obstructive pulmonary disease.